TicoVac 1.2 ug/.25mL
Tick-Borne Encephalitis Vaccine · INJECTION · Pfizer Laboratories Div Pfizer Inc
TicoVac is a injection containing tick-borne encephalitis vaccine at 1.2 ug/.25mL, taken intramuscular. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- TicoVac
- Generic Name
- Tick-Borne Encephalitis Vaccine
- NDC Code (Product)
0069-0297- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 1.2 ug/.25mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125740
- Marketing Start
- 06/27/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is TicoVac used for?
TicoVac contains Tick-Borne Encephalitis Vaccine. It is a injection taken intramuscular. Consult your doctor for specific uses.
Is TicoVac a controlled substance?
TicoVac is not classified as a controlled substance by the DEA.
What is the generic name for TicoVac?
The generic name for TicoVac is Tick-Borne Encephalitis Vaccine. There are no other listed brand versions of Tick-Borne Encephalitis Vaccine.
What is the NDC code for TicoVac 1.2 ug/.25mL?
The NDC (National Drug Code) for TicoVac 1.2 ug/.25mL is 0069-0297, listed by Pfizer Laboratories Div Pfizer Inc.
Other TicoVac Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)